Published in Case Rep Med on November 19, 2013
Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) (2007) 2.90
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Ann Rheum Dis (2008) 2.21
Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy. Semin Arthritis Rheum (2013) 1.77
Cutaneous sarcoidosis. Semin Respir Crit Care Med (2010) 1.69
Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology (1989) 1.21
Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin Endocrinol (Oxf) (2002) 1.08
The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure. Rheumatology (Oxford) (2013) 1.07
Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism. Clin Rheumatol (2007) 0.94
Exacerbation of hypothyroidism following tumor necrosis factor-alpha infusion. Intern Med (1992) 0.88
Tumor necrosis factor-alpha and interferon-gamma modulate gene expression of type I 5'-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinology (1995) 0.86
Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease. Australas J Dermatol (2013) 0.80